Aegerion Pharmaceuticals, Inc. (AEGR) Announces Presentation at the Bank of America (BAC) Merrill Lynch 2013 Healthcare Conference
5/3/2013 10:07:45 AM
More...
|
Aegerion Pharmaceuticals, Inc. (AEGR) Announces First-Quarter 2013 Financial Results
4/30/2013 2:40:36 PM
More...
|
Veristat, Inc.'s Collaboration With Aegerion Pharmaceuticals, Inc. (AEGR) Contributes to FDA Approval of Juxtapid™
3/20/2013 10:26:42 AM
More...
|
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Fourth-Quarter and Year-End 2012 Financial Results
3/6/2013 11:14:42 AM
More...
|
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Presentation at the Cowen and Company 33rd Annual Health Care Conference
2/27/2013 1:27:13 PM
More...
|
Pricey Aegerion Pharmaceuticals, Inc. (AEGR) Cholesterol Pill Worries Insurers
2/22/2013 7:36:49 AM
More...
|
Aegerion Pharmaceuticals, Inc. (AEGR) to Ring the NASDAQ Stock Market Closing Bell
1/22/2013 9:07:59 AM
More...
|
Aegerion Pharmaceuticals, Inc. (AEGR) Prices Public Offering of Common Stock
1/11/2013 9:33:08 AM
More...
|
Aptuit, Inc. and Aegerion Pharmaceuticals, Inc. (AEGR) Sign Commercial API Supply Agreement
1/8/2013 11:17:52 AM
More...
|
Catalent Pharma Solutions and Aegerion Pharmaceuticals, Inc. (AEGR) Partner on Launch of Newly FDA Approved JUXTAPID™
1/8/2013 9:22:58 AM
More...
|
|